BOULDER, Colo., Aug 29, 2007 (BUSINESS WIRE) -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief
Executive Officer, Robert E. Conway, will speak at the Thomas Weisel
Partners Healthcare Conference on September 5 in Boston. The public is
welcome to participate in the conference through a webcast on the
Array BioPharma website.
Event: Thomas Weisel Partners Healthcare Conference
Presenter: Robert E. Conway, Chief Executive Officer, Array BioPharma
Date: Wednesday, September 5, 2007
Time: 9:10 a.m. Eastern Time
Location: Four Seasons Boston
About Array BioPharma:
Array BioPharma Inc. is a biopharmaceutical company focused on the
discovery, development and commercialization of targeted small
molecule drugs to treat life threatening and debilitating diseases.
Our proprietary drug development pipeline is focused on the treatment
of cancer and inflammatory disease and includes clinical candidates
that are designed to regulate therapeutically important targets. In
addition, leading pharmaceutical and biotechnology companies
collaborate with Array to discover and develop drug candidates across
a broad range of therapeutic areas. For more information on Array,
please go to www.arraybiopharma.com.
SOURCE: Array BioPharma Inc.
Array BioPharma Inc.
Tricia Haugeto, 303-386-1193